Medical Devices - Electrosurgical and Advanced Energy Technology
Strategic Profile
Apyx's Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company operates in two segments: Advanced Energy and Original Equipment Manufacturing (OEM), with the Advanced Energy segment deriving the majority of its revenue.
Cyborg Score Rationale
The company generated $47.9M in trailing twelve-month revenue with negative EPS of -$0.36, reflecting profitability challenges. While Renuvion and J-Plasma effectiveness is supported by more than 90 clinical documents, the small market capitalization and modest revenue base present growth constraints.
Top Insights
AYON Body Contouring System is an FDA-cleared platform that combines fat removal, closed loop contouring, electrosurgical capabilities and Renuvion for tissue contraction
Current market capitalization is $164M with 41M shares outstanding as of late November 2025
Apyx, formerly Bovie® Medical, leverages deep expertise and decades of experience in unique waveforms
The company leverages its expertise through OEM agreements with other medical device manufacturers
Named Competitors
Electrosurgical Systems — Surgical instruments and electrosurgical equipment